Boston Scientific logo

BSX PR A - Boston Scientific News Story

$119.79 1.5  1.3%

Sector
Healthcare
Size
Large Cap
Market Cap £46.71bn
Enterprise Value £51.41bn
Revenue £8.16bn
Position in Universe th / 7170

Boston Scientific Corp reports results for the quarter ended in June - Earnings Summary

Tue 27th July, 2021 12:08pm
* Boston Scientific Corp  BSX.N  reported quarterly adjusted
earnings of 40 cents​​ per share for the quarter ended in June.
The mean expectation of twenty seven analysts for the quarter
was for earnings of 37 cents per share.
* Revenue rose 53.6% to $3.08 billion from a year ago;  analysts
expected $2.94 billion. 
* Boston Scientific Corp's reported EPS for the quarter was 12
cents​.
* The mean earnings estimate of analysts had risen by about 6.5%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Boston Scientific Corp shares had risen by 2.8% this
quarter and gained 22.3% so far this year.
* The company reported quarterly net income of $172 million.
* Wall Street's median 12-month price target for Boston
Scientific Corp is $50.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 27 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 27 at 11:08 a.m.  ​All
figures in US dollars unless otherwise stated
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.